Brasada Capital Management’s Pfizer PFE Stock Holding History

Brasada Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-657	Closed	-$27K	–	231
2018 Q4	$27K	Sell	657 -357	-35%	-$14.8K	0.01%	202
2018 Q3	$42K	Buy	+1,014	New	+$39K	0.01%	212
2018 Q2	–	Sell	-1,241	Closed	-$42K	–	316
2018 Q1	$42K	Sell	1,241 -948	-43%	-$32.6K	0.01%	197
2017 Q4	$75K	Buy	+2,189	New	+$74.6K	0.03%	169

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brasada Capital Management's PFE Position: Q1 2019 in Review

Brasada Capital Management sold out of Pfizer (PFE) in Q1 2019, closing a stake of 657 shares — an estimated $27K sold.

Brasada Capital Management first reported a position in PFE in Q4 2017 and held it in 4 quarters. The position peaked at $75K in Q4 2017. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

Brasada Capital Management reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
Brasada Capital Management sold 657 Pfizer shares in Q1 2019, an estimated $27K.
Brasada Capital Management first reported a position in Pfizer in Q4 2017 and held it in 4 quarters.
Brasada Capital Management's Pfizer position peaked at $75K in Q4 2017.
2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Brasada Capital Management's 13F filing for Q1 2019, filed 6 May 2019.